Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients

Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells

(2010) Yoshihiko Hirohashi et al.   Immunotherapy

Spatiotemporal Regulation of Heat Shock Protein 90-Chaperoned Self-DNA and CpG-Oligodeoxynucleotide for Type I IFN Induction via Targeting to Static Early Endosome

(2010) K. Okuya et al.   JOURNAL OF IMMUNOLOGY

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer

(2009) Ichiya Honma et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The functioning antigens: beyond just as the immunological targets

(2009) Yoshihiko Hirohashi et al.   CANCER SCIENCE

Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4

(2009) Munehide Nakatsugawa et al.   CANCER SCIENCE

Targeting to Static Endosome Is Required for Efficient Cross-Presentation of Endoplasmic Reticulum-Resident Oxygen-Regulated Protein 150-Peptide Complexes

(2009) G. Kutomi et al.   JOURNAL OF IMMUNOLOGY

Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients

(2009) Margherita Gigante et al.   JOURNAL OF IMMUNOTHERAPY

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma

(2009) Satoko Inoda et al.   JOURNAL OF IMMUNOTHERAPY

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

(2009) Ichiya Honma et al.   Journal of Translational Medicine

Molecular pathological approaches to human tumor immunology

(2009) Noriyuki Sato et al.   PATHOLOGY INTERNATIONAL

Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma

(2008) E. Sato et al.   CLINICAL CANCER RESEARCH

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

(2008) Tetsuhiro Tsuruma et al.   Journal of Translational Medicine